Evidence map›Paper›PMID 42839120›Full record

ArticleCurrent microbiology2026

Outbreak of Multidrug-Resistant (MDR) Acinetobacter baumannii ST-15 Strains Co-producing OXA-23 and OXA-58 in South America.

Aline Madeira Marques Saraiva, Amália Raiana Fonseca Lobato, Emanoele Saraiva Pereira, Maria Paula Cruz Schneider, Diego Assis das Graças, Adonney Allan de Oliveira Veras, Artur Silva, Danielle Murici Brasiliense, Rafael Azevedo Baraúna

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Current microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Aline Madeira Marques SaraivaBiological Engineering Laboratory, Guamá Science and Technology Park, Belém, 66075-750, Brazil.
Amália Raiana Fonseca LobatoBacterial Resistance Laboratory, Bacteriology Section, Evandro Chagas Institute, 67030-000, Ananindeua, Brazil.
Emanoele Saraiva PereiraBacterial Resistance Laboratory, Bacteriology Section, Evandro Chagas Institute, 67030-000, Ananindeua, Brazil.
Maria Paula Cruz SchneiderBiological Engineering Laboratory, Guamá Science and Technology Park, Belém, 66075-750, Brazil.
Diego Assis das GraçasBiological Engineering Laboratory, Guamá Science and Technology Park, Belém, 66075-750, Brazil.
Adonney Allan de Oliveira VerasBiological Engineering Laboratory, Guamá Science and Technology Park, Belém, 66075-750, Brazil.
Artur SilvaBiological Engineering Laboratory, Guamá Science and Technology Park, Belém, 66075-750, Brazil.
Danielle Murici BrasilienseBacterial Resistance Laboratory, Bacteriology Section, Evandro Chagas Institute, 67030-000, Ananindeua, Brazil.
Rafael Azevedo BaraúnaBiological Engineering Laboratory, Guamá Science and Technology Park, Belém, 66075-750, Brazil. rabarauna@ufpa.br.ORCID http://orcid.org/0000-0001-6654-2118

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Acinetobacter baumannii is a high-priority pathogen due to its global dissemination and antimicrobial resistance. This work describes the first report of A. baumannii ST-15 isolates belonging to the International Clone 4 group, that exhibited an MDR profile with the co-production of OXA-23 and OXA-58 enzymes. Strains were isolated from an intensive care unit in a hospital of the Brazilian Amazon. Eight strains were recovered from an intensive care unit, showing high clonal stability across diverse clinical sources, including tracheal aspirates, urine, and blood, which underscores the high versatility and systemic dissemination potential of this lineage.The bla

Indexed as

Acinetobacter baumanniiAcinetobacter InfectionsBacterial Proteinsbeta-LactamasesDisease OutbreaksDrug Resistance, Multiple, BacterialAnti-Bacterial AgentsBrazilGenome, BacterialHumansMicrobial Sensitivity TestsPlasmidsSouth AmericaAnti-Bacterial AgentsBacterial Proteinsbeta-lactamase OXA-23beta-lactamase OXA-58, Acinetobacter baumanniibeta-Lactamases

Identifiers

PMID42839120
PMCPMC13642431

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.